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Total hip arthroplasty (THA) and total knee arthroplasty 
(TKA) are common major surgical procedures that are 
often performed in older patients with complex comorbidi-
ties. Fast-track programs (or Enhanced Recovery after Sur-
gery (ERAS) programs) have evolved during the past 20 
years, and have been proven to reduce length of hospital 
stay (LOS), morbidity, and convalescence time, without an 
increase in readmission rates or compromising patient safety 
(Kehlet 2013, Khan et al. 2014, Berg et al. 2018, Petersen et 
al. 2018a). So far so good. However, even though patients 
may meet discharge criteria within 0–2 days, they have not 
completely recovered. In addition, despite the scientific evi-
dence for enhanced recovery, widespread implementation 
is still lagging, since LOS is still around 4–6 days in many 
places after THA and TKA compared with 2–3 days or less 
in large epidemiological studies (Khan et al. 2014, Berg et 
al. 2018, Petersen et al. 2018a). Therefore, the challenge is 
to further understand the pathophysiological mechanisms 
of morbidity and recovery, and to optimize post-discharge 
functional outcomes, in order to prevent sub-acute problems 
turning into chronic problems. 
Pain during early postoperative recovery is multifactorial 
with several contributors been identified, e.g. postoperative 
inflammatory/immunological responses, sufficient pain man-
agement and organizational factors (Kehlet 2013, Gaudilliere 
et al. 2014). Optimal pain management is a prerequisite to 
enhance recovery and plenty of analgesic techniques have 
been described for THA and TKA, but without firm conclu-
sions and recommendations (Karlsen et al. 2015, 2017, Soffin 
et al. 2018a, 2018b). Simple multimodal oral analgesia sup-
plemented by a high dose of preoperative glucocorticoid is 
probably the simplest and safest option to enhance analgesia 
and early recovery (Kehlet and Lindberg-Larsen 2018), with 
use of local infiltration analgesia (LIA) in TKA but without 
the use of more specific peripheral nerve blocks. The latter 
seemingly provide better immediate postoperative pain relief, 
but have not led to shorter LOS, nor have they demonstrated 
long-lasting improved recovery. 
Since early ambulation is essential, the problem of early 
postoperative orthostatic intolerance is important, and studies 
have shown an undesirable shift in autonomic nervous system 
function towards increased parasympathetic function and loss 
of sympathetic stimulation, especially to the lower legs (Jans 
and Kehlet 2017). So far, the problem has not been solved by 
optimized fluid management, while some positive data using 
an α-1 agonist (midodrine) needs further study (Jans and 
Kehlet 2017).
Recently, more emphasis has been put on the role of pre- 
and postoperative anemia as risk factors for a prolonged hos-
pital stay and re-admission after THA and TKA, clearly docu-
menting the need for the effective preoperative diagnosis and 
treatment of anemia (Munoz et al. 2017). Intraoperative blood 
loss should be decreased by use of combined local and sys-
temic tranexamic acid treatment, while the influence of post-
operative anemia remains to be explored further especially in 
elderly patients and with a focus on cardiovascular complica-
tions and functional recovery. In addition, studies are required 
to evaluate the optimal transfusion triggers in specific high-
risk patients, which unfortunately have not been included in 
previous THA and TKA transfusion guidelines due to lack 
of sufficient data (Munoz et al. 2017, 2018, Petersen et al. 
2018a). 
Postoperative delirium and cognitive dysfunction are well-
recognized problems after surgery in general where the patho-
genesis is again multifactorial and includes pain, use of opi-
oids, sleep disturbances and inflammatory responses (Kehlet 
2013). Recent large-scale data from fast-track THA and TKA 
have shown virtually no risk of early delirium (Petersen et al. 
2017). Nevertheless, postoperative sleep disturbances (Kehlet 
2013) are still present and may also be related to post-dis-
charge functional recovery where the combination of pain, 
function and sleep disturbances are dominant and where 
future studies should clarify the relative role of each compo-
nent (Krenk et al. 2010).
The final challenge lies in safety as a further reduction of 
morbidity and mortality, which is well documented in fast-
track THA and TKA (Kehlet 2013, Khan et al. 2014, Jor-
gensen et al. 2016). An effort to construct a prediction risk 
including all conventional risk factors showed that this could 
be done with statistical significance, although the clinical sig-
nificance was less due to the low numbers of complications, 
especially when separated between direct “medical” and “sur-
gical” complications (Jorgensen et al. 2016). Part of the prob-
lem is that not only preoperative risk factors are important, 
but also the perioperative care regimes including avoidance 
of postoperative anemia. Although there is general agreement 
that fast-track THA and TKA decreases the risk of “medical” 
complications, the concern that early discharge may lead to 
more “surgical” complications (hip dislocation, wound prob-
lems, etc.) has not been supported by the literature (den Hartog 
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et al. 2013, Khan et al. 2014, Jorgensen et al. 2016, Sutton et 
al. 2016, Pamilo et al. 2018).
Recent evidence points to patients with preoperative “psy-
chiatric” conditions on psychopharmacological treatment – 
mostly with conventional antidepressants – as being at risk 
for prolonged LOS and more readmissions. Detailed analysis 
suggests that these recovery issues are related to the psycho-
pharmacological treatment per se rather than the “psychiat-
ric” condition, calling for future interventional studies in such 
patients (Gylvin et al. 2017).
The risk of post THA/TKA thromboembolic complications 
is well known and has been a classical model in thromboem-
bolic prophylactic studies. However, even the most recent 
guidelines (NICE 2018) are predominantly based on studies 
with prolonged LOS and thus not reflective of the benefits 
of early postoperative mobilization (Kjaersgaard-Andersen 
and Kehlet 2012). More recent prospective data from large 
cohort studies suggest that conventional prolonged thrombo-
embolic prophylaxis may not be necessary within a successful 
enhanced recovery THA/TKA program including early mobi-
lization (Kehlet 2013, Petersen et al. 2018b); this needs cor-
roboration with further large-sized studies.
Whilst early ambulation and reduced LOS has reduced the 
risk of complications, the early loss of muscle function may 
delay post-discharge recovery. Despite considerable efforts 
to improve rehabilitation, the use of preoperative exercise, 
conventional physiotherapy regimes, and earlier initiated and 
more intense postoperative strengthening regimes have all 
been found to have a limited effect in the “average” patient 
(Bandholm et al. 2018). Therefore, future work in fast-track 
THA and TKA must reveal which therapeutic interventions 
are effective, and in which patients with known preopera-
tive indicators of likely delayed recovery such as pain status, 
frailty, psychological status, socioeconomic status, and unre-
alistic expectations of recovery. Although patient-reported 
outcome measures (PROMs) show improvement in the major-
ity of fast-track THA and TKA patients, discrepancies are 
seen when compared with objective measures of functional 
performance and physical activity, both in the early and later 
recovery phase (Luna et al. 2017, 2018). Consequently, objec-
tive functional data are important from future studies, given 
the known increased healthcare costs and lower income levels 
of patients even after fast-track THA and TKA (Kjellberg and 
Kehlet 2016).
Although LOS in several countries has been reported to be 
short (Kehlet 2013), the aim is to improve recovery to be able 
to go directly home and not via another institution such as 
nursing care facilities, rehabilitation homes etc. (Cram et al. 
2018) where limited scientific information is available with 
regard to recovery interventions and results. The same applies 
to the more recent publications on outpatient THA and TKA, 
often from private and semi-private institutions. So far, this 
approach seems safe in selected patients without increasing 
risk of readmissions or complications (Vehmeijer et al. 2018). 
However, despite this progress, there are challenges to under-
stand how to increase the percentage of patients recovered and 
discharged on the day of surgery, and for which patients that 
outpatient surgery may not equate to optimized care. Fast-
track protocols have been based on the concept of “first better 
– then faster,” so it could be that for some identified patients a 
planned longer stay in hospital is the best means of accelerat-
ing recovery and reducing complications, re-admissions, and 
morbidity. 
In summary, the fast-track THA and TKA approach has 
made major progress, but we have not achieved the final goal. 
Future challenges lie in: (1) preoperative prediction of high-
inflammatory responders, (2) further dose-finding or repeat-
dosing glucocorticoid or other anti-inflammatory agents in 
studies in hyper-inflammatory responders (Kehlet and Lind-
berg-Larsen 2018), (3) more focused studies on high-pain 
responders (preoperative opioid users, pain catastrophizers, 
sensitized patients, etc.) (Gilron et al. 2018), and (4) develop-
ing optimal post-discharge rehabilitation strategies. Only then 
we will have succeeded ino reaching the goal for the “pain and 
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